AURKB can boost the development of ccRCC by activating a number of signaling pathways, including cell adhesion molecules (CAMs), natural killer cell-mediated cytotoxicity, the cell cycle, the intestinal immune network for IgA production, and cytokine-cytokine receptor interaction [53]. This evidence concerns the gene CD79A and nonpapillary renal cell carcinoma.